The observed association for prostate cancer is in agreement with a recent MR study where TYK2 inhibition mimicked by a loss-of-function variant in TYK2 (rs34536443) showed associations with lung cancer, non-Hodgkin lymphoma, and advanced prostate cancer.9 The gene discussed is TYK2; the disease is lung carcinoma.